NCT07845214Not yet recruiting
Effects of Horticultural Therapy on Acute Stress and Salivary Cortisol Levels in Hemodialysis Patients
The Effect of Horticultural Therapy Applied to Hemodialysis Patients on Acute Stress and Salivary Cortisol Levels: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 28 Oct 2026
Brief summary (registry, in English)
The purpose of this study is to evaluate the acute psychological and physiological effects of a single-session structured horticultural therapy program on patients undergoing routine hemodialysis. The study is designed as a two-arm, parallel, pretest-posttest randomized controlled trial conducted at Bingöl State Hospital. Participants are randomized (1:1) to either an experimental group receiving a 45-60 minute individual horticultural therapy session (e.g., planting and caring for Tagetes erecta, Celosia cristata, and Petunia grandiflora) or a control group maintaining standard waiting conditions for the same duration during non-dialysis days. Primary outcomes evaluate acute changes in state anxiety (measured via STAI-1) and physiological stress response (measured via salivary cortisol concentration) before and immediately after the intervention.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- First submitted
- 22 Sept 2026
- Start date
- 15 Oct 2026
- Primary completion date
- 15 Nov 2026
- Lead sponsor
- Ataturk University
- Diseases
- Chronic kidney disease
- NCT number
- NCT07845214
What you commit to
- Study type: Interventional
- Planned participants: 80
- From 15 Oct 2026 to the primary completion date, 15 Nov 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current use of systemic corticosteroid therapy or medications significantly altering cortisol metabolism
- Regular participation in any formal complementary/alternative therapy or plant-ca
Other illness
- Severe physical, motor, or visual impairment preventing participation in horticultural activities
- Active acute infection or severe systemic disease flare
- Severe psychiatric illness or cognitive impairment (e.g., dementia) diagnosed by a physician
Criteria the registry did not label
- ClinicalTrials.gov (PRS) sistemindeki Eligibility Criteria alanına birebir yapıştırabileceğiniz İngilizce format ve Türkçe anlamı aşağıdadır: Sisteme Girilecek Metin (İngilizce Format)PlaintextInclusion Criteria:
- Age between 18 and 65 years
- Receiving maintenance hemodialysis treatment for at least 6 months
- Receiving hemodialysis 3 times a week, 4 hours per session
- Cognitive ability to comprehend and complete study questionnaires
- Willingness to participate in the study and signing the informed consent form
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.